110 related articles for article (PubMed ID: 23735857)
41. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.
Meleshko AN; Savva NN; Fedasenka UU; Romancova AS; Krasko OV; Eckert C; von Stackelberg A; Aleinikova OV
Leuk Res; 2011 Oct; 35(10):1312-20. PubMed ID: 21596436
[TBL] [Abstract][Full Text] [Related]
43. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
[TBL] [Abstract][Full Text] [Related]
44. Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.
Mansur MB; van Delft FW; Colman SM; Furness CL; Gibson J; Emerenciano M; Kempski H; Clappier E; Cave H; Soulier J; Pombo-de-Oliveira MS; Greaves M; Ford AM
Br J Haematol; 2015 Nov; 171(4):574-84. PubMed ID: 26205622
[TBL] [Abstract][Full Text] [Related]
45. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL).
Genescà E; Morgades M; González-Gil C; Fuster-Tormo F; Haferlach C; Meggendorfer M; Montesinos P; Barba P; Gil C; Coll R; Moreno MJ; Martínez-Carballeira D; García-Cadenas I; Vives S; Ribera J; González-Campos J; Díaz-Beya M; Mercadal S; Artola MT; Cladera A; Tormo M; Bermúdez A; Vall-Llovera F; Martínez-Sánchez P; Amigo ML; Monsalvo S; Novo A; Cervera M; García-Guiñon A; Ciudad J; Cervera J; Hernández-Rivas JM; Granada I; Haferlach T; Orfao A; Solé F; Ribera JM
Leuk Res; 2021 Oct; 109():106612. PubMed ID: 34139642
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.
Mroczek A; Zawitkowska J; Kowalczyk J; Lejman M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467425
[TBL] [Abstract][Full Text] [Related]
47. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Coustan-Smith E; Mullighan CG; Onciu M; Behm FG; Raimondi SC; Pei D; Cheng C; Su X; Rubnitz JE; Basso G; Biondi A; Pui CH; Downing JR; Campana D
Lancet Oncol; 2009 Feb; 10(2):147-56. PubMed ID: 19147408
[TBL] [Abstract][Full Text] [Related]
48. Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome.
Milani G; Rebora P; Accordi B; Galla L; Bresolin S; Cazzaniga G; Buldini B; Mura R; Ladogana S; Giraldi E; Conter V; Te Kronnie G; Valsecchi MG; Basso G
Oncotarget; 2014 Jul; 5(14):5234-45. PubMed ID: 25026300
[TBL] [Abstract][Full Text] [Related]
49. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
[TBL] [Abstract][Full Text] [Related]
50. A Smart Detection System Based on Specific Magnetic and Rolling Cycle Amplification Signal-Amplified Dual-Aptamers to Accurately Monitor Minimal Residual Diseases in Patients with T-ALL.
Li X; Zhou B; Zhao Z; Hu Z; Zhou S; Yang N; Huang Y; Zhang Z; Su J; Lan D; Qin X; Meng J; Zheng D; He J; Huang X; Zhao J; Zhang Z; Tan W; Lu X; Zhao Y
J Biomed Nanotechnol; 2016 Dec; 12(12):2151-60. PubMed ID: 29369551
[TBL] [Abstract][Full Text] [Related]
51. T-cell acute lymphoblastic leukemia.
Raetz EA; Teachey DT
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):580-588. PubMed ID: 27913532
[TBL] [Abstract][Full Text] [Related]
52. Monitoring of minimal residual disease in early T-cell precursor acute lymphoblastic leukaemia by next-generation sequencing.
Pan X; Nariai N; Fukuhara N; Saito S; Sato Y; Katsuoka F; Kojima K; Kuroki Y; Danjoh I; Saito R; Hasegawa S; Okitsu Y; Kondo A; Onishi Y; Nagami F; Kiyomoto H; Hozawa A; Fuse N; Nagasaki M; Shimizu R; Yasuda J; Harigae H; Yamamoto M
Br J Haematol; 2017 Jan; 176(2):318-321. PubMed ID: 26822323
[No Abstract] [Full Text] [Related]
53. Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies.
Ceppi F; Gotti G; Möricke A; Silvestri D; Poyer F; Lentes J; Bergmann A; Trka J; Alten J; Elitzur S; Barbaric D; Buldini B; Dell'Acqua F; Schumacher F; Casazza G; Tchinda J; Nebral K; Conter V; Attarbaschi A; Schrappe M
Eur J Cancer; 2022 Nov; 175():120-124. PubMed ID: 36113241
[TBL] [Abstract][Full Text] [Related]
54. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
De Bie J; Quessada J; Tueur G; Lefebvre C; Luquet I; Toujani S; Cuccuini W; Lafage-Pochitaloff M; Michaux L
Curr Res Transl Med; 2023; 71(4):103431. PubMed ID: 38016418
[TBL] [Abstract][Full Text] [Related]
55. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.
Starý J; Zuna J; Zaliova M
F1000Res; 2018; 7():. PubMed ID: 30345005
[TBL] [Abstract][Full Text] [Related]
56. [Acute lymphoblastic leukemia of T progenitors: from biology to clinics].
Genescà E; Ribera J; Ribera JM
Med Clin (Barc); 2015 Mar; 144(5):223-9. PubMed ID: 24667111
[TBL] [Abstract][Full Text] [Related]
57. Cortactin Expression is a Novel Biomarker for Risk Stratification of T-Cell Acute Lymphoblastic Leukemia.
Aref S; Fawzy E; Darwish A; Aref M; Agdar MA
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e798-e803. PubMed ID: 33235155
[TBL] [Abstract][Full Text] [Related]
58. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia.
Ma X; Wen L; Wu L; Wang Q; Yao H; Wang Q; Ma L; Chen S
Cancer Genet; 2015; 208(1-2):52-3. PubMed ID: 25749351
[No Abstract] [Full Text] [Related]
59. MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.
Gębarowska K; Mroczek A; Kowalczyk JR; Lejman M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070107
[TBL] [Abstract][Full Text] [Related]
60. The effect of TLX3 expression on the prognosis of pediatric T cell acute lymphocytic leukemia--a systematic review.
Ma J; Hua J; Sha Y; Xie Y
Tumour Biol; 2014 Sep; 35(9):8439-43. PubMed ID: 24997618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
